A Pilot Trial of Topical vs Oral Minoxidil for Treatment of Endocrine Therapy-Induced Alopecia in Breast Cancer Patients
This study is testing two ways to treat hair thinning and loss caused by hormone-blocking breast cancer therapies. Researchers want to see if applying minoxidil directly to the scalp or taking it as a pill can help women keep or regrow their hair.
You may be able to join if you are a woman 18 or older with stage I to IV breast cancer who is experiencing hair loss after starting hormone-blocking therapies. You must not have used minoxidil before or received chemotherapy in the past two years.
Participants will receive either a topical scalp treatment or an oral pill containing minoxidil to help with hair growth. You will also be asked to fill out questionnaires about your overall well-being and daily comfort.
The study is currently recruiting participants and takes place in Columbus, Ohio, United States.
- 1Tests topical versus oral minoxidil for hair loss from breast cancer treatments
- 2Open to women with stage I-IV breast cancer experiencing hair thinning
- 3Involves taking study medication and completing health surveys
Related links
Outside pages about this study, checked by our team
This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.